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Abstract
The nasopharynx is the main ecological niche of the human pathogen Staphylococcus aureus. Although colonization of the
nares is asymptomatic, nasal carriage is a known risk factor for endogenous staphylococcal infection. We quantified S.
aureus mRNA levels in nose swabs of persistent carriers to gain insight into the regulatory adaptation of the bacterium to
the nasal environment. We could elucidate a general response of the pathogen to the surrounding milieu independent of
the strain background or the human host. Colonizing bacteria preferentially express molecules necessary for tissue
adherence or immune-evasion whereas toxins are down regulated. From the analysis of regulatory loci we found evidence
for a predominate role of the essential two-component system WalKR of S. aureus. The results suggest that during persistent
colonization the bacteria are metabolically active with a high cell surface turnover. The increased understanding of bacterial
factors that maintain the colonization state can open new therapeutic options to control nasal carriage and subsequent
infections.
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Introduction
Staphylococcus aureus is both a major human pathogen and a
ubiquitous commensal and colonizer of the skin and mucous
membranes. Although multiple body sites can be colonized, the
anterior nares form the main ecological niche of this species.
Approximately 20% of the healthy human population is
persistently and 80% intermittently colonized with S. aureus in
the nose [1]. Nasal carriage has been identified as a major risk
factor for the development of subsequent mostly endogenous
infections [2,3].
Several bacterial factors were determined to be involved in S.
aureus nasal colonization: the wall teichoic acid (WTA) [4],
clumping factor B (clfB) [5], the capsular polysaccharide (cap) [6],
the iron-regulated surface determinant IsdA (isdA) [7], and the
autolysin SceD (sceD) [8]. All factors were so far studied in vitro or
in animal models with the exception of the adhesin ClfB, whose
causal involvement was shown in humans [5]. Expression of most
virulence and adherence factors were shown in vitro to be directly
or indirectly influenced by diverse regulators such as the accessory
gene regulator (Agr), the alternative sigma factor B (SigB), and the
sae locus [9,10,11,12]. The composition of the cell envelope is
modified by the regulatory action of graRS (also known as apsXRS)
[13,14] or the essential regulatory system walKR [15].
A better understanding of the bacterial factors maintaining the
colonization state can be important for controlling nasal carriage
and subsequent infections. In the present study transcript analysis
using quantitative real-time PCR was performed directly on nose
swabs from persistently colonized healthy individuals. We could
show that in the human nose most global virulence regulators are
not active, with exception of the essential two-component
regulatory system WalKR. Furthermore, S. aureus nasal coloniza-
tion is characterized by the expression of genes mediating
adhesion, cell surface dynamics/remodeling, the expression of
immune evasion genes and the lack of toxin transcription.
Results
Characteristics of nose specimens from healthy S. aureus
nose carriers
For the analysis of S. aureus gene expression during human nose
colonization we selected four persistently colonized individuals (A,
B, C and D) with a history of repeated S. aureus-positive nose
swabs. None of the volunteers received any antibiotics immedi-
ately before or between samplings. In general, S. aureus loads in the
nose varied considerably over time, as exemplified for the two
carriers A and D (Fig. 1). Specimens for transcript analysis were
collected at two different time points: at the first sampling nose
swabs were obtained from all four individuals, and at the second
sampling 12 months later they were collected only from individual
A and D. CFUs between 10
4–10
5/swab were detected in the noses
of the volunteers at these time points. Bacteriological analysis
revealed that all volunteers were colonized with a single S. aureus
phenotype over time with the exception of individual A who
carried a hemolytic and a non-hemolytic strain simultaneously at
the second sampling (table 1). All carriers were colonized by
distinct clones. Individuals A and D retained the same S. aureus
strain over the whole investigation period. Detection of genes
encoded on mobile elements revealed that none of the isolates
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Valentine leukocidin gene. All nose isolates were lysogenic for hlb-
converting phages encoding either staphylokinase (sak), the
staphylococcal complement inhibitor (scn) and/or chemotaxis-
inhibitor protein (chp) with exception of the ß-hemolysin (HLB)
producing variant of individual A.
Most of the regulatory circuits controlling S. aureus gene
expression have been described for prototypic strains. However,
clinical isolates often exhibit a different regulation pattern. To
elucidate the general properties of our four nose isolates we first
analyzed the bacteria under in vitro conditions with quantitative
RT-PCR (table S2) and for selected genes by Northern Blot
analysis in comparison with the three characterized S. aureus strains
Newman, HG001 and USA300 (Fig. 2). So far no expression data
in S. aureus were available for the essential two-component system
walKR. We could show that it is maximally transcribed during the
post-exponential phase in all nose isolates and in strain Newman.
Next we determined transcription of phenol-soluble modulin
(encoded by psm), which until now has only been described for
caMRSAs such as USA300 [16]. We could detect an equally high
expression in the post-exponential phase in all strains. In
prototypic strains protein A is maximally expressed during the
exponential phase due to the repressive action of the global
regulator agr [17]. This could be confirmed but none of the four
nose isolates showed the typical transcription pattern. Similar
results were already obtained by us for CF isolates [18]. The
immune-modulator molecule scn was reported to be transcribed
mainly during exponential growth [19]. We could not reproduce
this observation either in the nose isolates or in the three
laboratory strains.
Direct transcript analysis in nose swabs from S. aureus
carriers
To profile the expression pattern of S. aureus during nasal
colonization we performed quantitative transcript analysis directly
on nose swabs obtained from persistent carriers. 30 different genes
associated with a variety of cellular functions such as virulence
regulation, toxin production, adhesion, cell wall dynamics and
modification, immune modulation, SOS response and metabolic
regulation were selected as targets (table S2). The transcript levels
of all the target genes could be reliably quantified in these nose
specimens with the exception of four genes: the mRNAs of mprF,
dltA, isaA, and ica were below the detection level. In addition, these
targets could only be detected from bacteria grown in vitro when
100-fold concentrated template RNA was analyzed, emphasizing
the very low levels of these transcripts. The mRNA of the
remaining 26 genes was quantified in the ex vivo material from the
nose and compared to the transcription of the nose isolates during
Figure 1. Bacterial loads in the noses of two persistent S. aureus carriers (individuals D and A) over time. Bacterial numbers are given in
colony-forming units (CFU/ml) over a period of two years illustrated in days. Arrows indicate the time point of RNA isolation for quantitative real-time
PCR.
doi:10.1371/journal.pone.0010040.g001
Table 1. Characteristics of nose isolates from four persistent carriers.
Individual Sampling
a Phenotype
b GT
c spa-type CC
Prophage
content
d
Accessory gene
content
e
A 1 non-hemolytic 2 t1239 CC30 Sa6, Sa3, Sa2 sak, chp, scn
A 2 non-hemolytic
f 2 nd CC30 Sa6, Sa3, Sa2 sak, chp, scn
A 2 hemolytic, ß 2 nd CC30 Sa6, Sa2 -
B 1 hemolytic 241 t1200 excluded Sa3 sak, chp, scn
C 1 hemolytic 253 t136 singleton Sa5, Sa3 sak, scn
D 1 hemolytic 7 t015 CC45 Sa3 sak, chp, scn
D 2 hemolytic 7 nd CC45 Sa3 sak, chp, scn
a. time point of sampling.
b. phenotype of S. aureus nose isolate on sheep blood agar plates.
c. genotype, determined by pulsed-field gel electrophoresis ß: positive for ß-hemolysin.
d. prophage content of isolates determined by identification of integrase gene type.
e. determined by standard PCR.
f. non-hemolytic phenotype 250 times more prominent, nd: not determined, - negative PCR result.
doi:10.1371/journal.pone.0010040.t001
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each of the four carriers were analyzed and the ratio of in vivo to
minimal or maximal expression in vitro was calculated (Fig. 3A, B).
Two of the four original carriers were sampled again 12 months
after the first time point and multiple swabs were obtained for
statistical analysis. The results are depicted as absolute copy
numbers in reference to the housekeeping gene gyrB and in
comparison with the expression profile in vitro (Fig. 4, 5). In the
following the main results derived from both samplings are
summarized according to the functional categorization of target
genes:
i.) Global regulators
Characteristically, S. aureus expresses adhesins in the early stages
of growth, whereas toxins are produced in the late stages. A
complex regulatory network is responsible for this differential gene
expression, which is tightly controlled in response to cell density,
energy availability and environmental signals. In our study we
investigated the activity of five prominent regulators: agr, sae, sigB
(detected as the tightly sigB-dependent asp), graRS and walKR. All
regulators with the exception of walKR were inactive during nose
colonization, as shown by the low expression in vivo compared to
maximal expression of the same strains in vitro (Fig. 3, 4). In
contrast, the essential two-component system WalKR was highly
transcribed in the noses of individual A and D similar to the
maximal expression during the post-exponential phase, suggesting
a role of this regulator during colonization (Fig. 4).
ii.) Toxins
Invasion of host tissue, bacterial spread, and lysis of host cells is
mediated by different types of S. aureus toxins. These molecules are
usually expressed in high amounts during post-exponential growth
(table S2). Transcript analysis of the alpha-hemolysin (hla), psm and
a bi-component leukotoxin homologue termed blhB revealed that
in all individuals these toxins were only poorly expressed in vivo
(Fig. 3, 4).
iii.) Adhesins
In S. aureus, cell-wall-anchored proteins and other adhesive
molecules are implicated in binding to host matrix molecules and
may therefore play an essential role in the establishment of
colonization. This is consistent with the maximal expression of
most adhesins during exponential growth (table S2). A pro-
nounced transcription of the adhesins clfB, fnbAa n disdA could be
observed in the nose swabs of all investigated carriers (Fig. 3, 4).
In contrast, transcript analysis of the post-exponentially expressed
adhesins clfAa n deap revealed a weak transcription during
colonization.
The WTA of S. aureus is known to be an important colonization
factor mediating adherence to epithelial and endothelial cells [20].
A multitude of enzymes are involved in WTA biosynthesis, but
little is known about their regulation. We characterized the role of
the WTA during colonization by analyzing the expression of tagO
and tarK, which both contribute to WTA biosynthesis [4,21]. We
detected high transcriptional levels of both enzymes in vivo and a
constant expression during growth in vitro (Fig. 4).
iv.) Cell-wall modification enzymes
Enzymes involved in cell wall remodeling contribute especially
to resistance against antimicrobial peptides. For instance,
resistance to lysozyme is mediated by the O-acetyltransferase
(oatA) [22] which was shown to be highly expressed during
colonization (Fig. 3, 4). A pronounced in vivo expression was also
detected for the autolysins atlA and sceD.
Figure 2. Expression pattern of the nose isolates of individuals A–D and of the laboratory strains Newman, HG001 and USA300
grown to the exponential (OD600=0.5) and post-exponential (OD600=6) growth phase. RNA was hybridized with probes specific for
walKR, psm, spa and scn. The 16S rRNA detected in the ethidium bromide-stained gels is indicated as a loading control in the lowest panel. The
absolute transcript amounts determined by quantitative real-time RT-PCR are given below each lane. nd, not determined.
doi:10.1371/journal.pone.0010040.g002
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Bacterial exposure to stress conditions triggers the SOS response
in which the RecA protein is the key enzyme. To test whether
exogenous pressure is exerted on S. aureus in the nose we measured
recA transcription. Expression was generally similar to or even
below the minimal expression in vitro (Fig. 3), indicating the
absence of SOS stimuli in the nasal environment.
Next we analyzed the activity of two metabolic regulators to
gain insight into the physiological state of S. aureus during
colonization. Bacteria adapt to amino acid insufficiency by a
complex series of regulatory events known as the ‘‘stringent
response’’ in which the bifunctional enzyme RelA is a key factor
[23]. The repressor CodY has been described as inhibiting genes
mainly involved in nitrogen metabolism [24]. Measurement of relA
codY transcription during colonization revealed a basal expression
of both metabolic regulators in the human nose (Fig. 3).
vi.) Immune evasion and immune modulatory factors
Protein A is a cell-wall-anchored protein involved in multiple
immune-modulatory processes [25,26]. In all nose specimens with
the exception of individual C spa transcription could be detected
suggesting a positive role of this molecule (Fig. 3, 4). S. aureus
produces extracellular capsular polysaccharide, which is thought
to protect the pathogen against opsonophagocytic killing by
polymorphonuclear leukocytes [27]. Expression analysis of the cap
operon revealed low-level production during nose colonization in
most of the individuals.
In S. aureus prophages which integrate specifically into the ß-
hemolysin (Hlb) gene are widely distributed, especially in nose
isolates [28]. These prophages typically encode immune evasion
molecules like SAK, SCIN, and CHIPS, which may contribute to
the colonization capability of the bacterium by interacting with the
host’s innate immune system [29]. Transcript analysis of sak and
Figure 3. Direct transcript analysis of S. aureus genes in the nose of four persistent S. aureus carriers (A–D). Results are stated as the ratio
of transcription in vivo versus minimal expression in vitro (A) and versus maximal expression in vitro (B). Changes in gene expression were normalized
in reference to the constitutively expressed gene gyrB. Genes colored red are those which were up-regulated compared to in vitro and genes colored
green are those which were down-regulated compared to in vitro. Black indicates the same expression levels in vivo and in vitro. Results are the
means of two separate samplings. Gene name abbreviations see table S2. The color chart was generated using GENESIS software version 1.7.2. [51].
doi:10.1371/journal.pone.0010040.g003
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persistent colonization since expression of both was clearly
pronounced compared to the expression during growth in vitro
(Fig. 3, 4, 5). In contrast, transcript analysis of the other phage-
encoded immune-evasion gene scn revealed only a weak expression
in vivo.
Differences in S. aureus gene expression depending on
host and time
S. aureus gene expression during colonization may be influenced
by individual factors and therefore vary in the different human
hosts. However, most of the analyzed transcripts were expressed in
similar amounts in all carriers, suggesting a general response of the
pathogen to the nasal environment. This was most obvious when
analyzing transcripts which showed a highly variable expression
during growth in culture, e.g., spa and cap. Individual A harbored a
strain with high in vitro spa expression level (up to 70 copies spa/
gyr) whereas the strain from individual D was a weak producer
(0.4 copies spa/gyr). For both strains in vivo transcript levels of 4–8
copies spa/gyr could be detected. Similarly cap transcription
leveled out during nose colonization (Fig. 3). clfB and chp, on the
other hand, were not uniformly expressed in the noses of all
individuals (Fig. 5).
Nasal colonization may necessitate a constant adaptation of the
pathogen to its environment, which is probably reflected in a
change in gene expression over time. However, when we
reanalyzed S. aureus transcription in the noses of two of the
original four carriers after 12 months, expression levels of most of
the analyzed genes had remained unchanged in comparison to the
first sampling. The only differently expressed genes were the luk-
homologue blhB and the adhesin eap, which were more highly
expressed at the second sampling (Fig. 4).
Discussion
The human nose is the primary reservoir of S. aureus, and
evolution of the species was probably driven by adaptation to this
milieu. In general, bacteria react to environmental stimuli by
differential gene expression which is controlled by various
interacting regulatory networks. Our results indicate that in the
nose important adhesive molecules (clfB, isdA, fnbA, atlA, eap,
WTA), genes involved in cell surface dynamics/remodeling (sceD,
oatA, atlA), and immune-modulatory factors (sak, chp, spa, eap) are
prominently expressed, whereas major toxins (hla, psm) are not
transcribed. Adherence to human desquamated nasal epithelial
cells is an important factor in successful nasal colonization and was
shown to be mediated by clfB, isdA and WTA in vitro [7,30], in the
Figure 5. Direct transcript analysis of S. aureus clumping factor B (clfB) and chemotaxis inhibitory protein (chp) in the nose of two
persistent carriers (individual A and D) twelve months after the first sampling. Transcripts were quantified in reference to the transcription
of gyrB directly in the nose swabs (in vivo, black columns) and after growth in culture to the exponential phase (exp, white columns) and the post-
exponential phase (pxp, gray columns). Values from three separate samplings (individual A) and four separate samplings (individual D), respectively
were used to calculate the mean expression. Statistically significant differences between the in vivo and in vitro results are indicated: ns, not
significant, P.0.05; * P,0.01 to ,0.05; ** P,0.001 to 0.01; *** P,0.001.
doi:10.1371/journal.pone.0010040.g005
Figure 4. Direct transcript analysis of S. aureus genes in the nose of of two persistent carriers (individuals A and D) twelve months
after the first sampling. Transcripts were quantified in reference to the transcription of gyrB directly in the nose swabs (in vivo, black columns) and
after growth to the exponential phase (exp, white columns) and the post-exponential phase (pxp, gray columns). Values from three separate
samplings (individual A) and four separate samplings (individual D), respectively were used to calculate the mean expression. Statistically significant
differences between the in vivo and in vitro results are indicated: ns, not significant, P.0.05; * P,0.01 to ,0.05; ** P,0.001 to 0.01; *** P,0.001.
Gene name abbreviations see table S2.
doi:10.1371/journal.pone.0010040.g004
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Thus, known colonization factors could indeed be proven to be
activated on the transcriptional level in the nose by S. aureus. This
supports our assumption that the results obtained from expression
profiling can unravel essential factors for nose adaptation.
Nasal secretions form the first line of defence of the innate
immune system against inhaled bacteria [33,34]. The pathogen is
able to counteract the most important mechanisms, namely
antimicrobial molecules such as defensins and lysozyme, the
complement system, immunoglobulins and phagocytes. S. aureus is
lysozyme-resistant due to the combined action of OatA and WTA
[22], both of which are produced by the pathogen during nose
colonization. The highly transcribed staphylokinase is able to bind
alpha-defensins, thus inhibiting their bactericidal effects [35]. In
addition, SAK is able to activate surface-bound plasminogen into
plasmin, which than has the ability to cleave the complement
compound C3b and IgG, thereby efficiently preventing opsoniza-
tion and subsequent phagocytosis by neutrophils [36]. Comple-
ment activation and opsonization are also blocked by the
expression of protein A [25]. Surprisingly, we could not detect
expression of the important complement inhibitor SCIN in the
nose although it was shown that nasal secretions contain
complement proteins [37].
To gain insight into the underlying regulatory network we
analyzed five prominent regulators. The virulence regulators agr,
sigB and sae were not activated during nose colonization.
Accordingly, the typical target genes were only weakly expressed,
toxins which are regulated by agr and sae, and clfA which is
regulated by sigB [10,38]. Surprisingly, the graRS system which
controls specific resistance mechanisms against antimicrobial
peptides [13,22] was not expressed either, despite various cationic
antimicrobial peptides in the nasal fluid. This low graRS expression
is consistent with the high expression of oatA (generally down-
regulated by graRS) and the low expression of the two genes dltA
and mprF (both strongly activated) [22]. However, another
positively influenced factor, the autolysin atlA, was strongly
expressed in the nose, indicating additional regulatory activators
for this gene. Indeed, we could show that the essential, two-
component system WalKR is active during nose colonization.
Although only some of the target genes are known, it is interesting
to note that atlA, sceD and sak are all positively regulated by
walKR [39]. These factors were all expressed in the human nose.
Thus, the WalKR regulatory system may play an important role in
adaptation to the nasal environment. This is supported by our
recent finding that the WalKR system is also the master regulator
of adaptive gene expression in a cotton-rat model of nose
colonization [40]. Furthermore, the high expression of cell wall
metabolism genes (atlA, sceD) as well as the activity of WalKR
strongly indicate that cell wall dynamics are critical for host-
pathogen interaction and prolonged colonization of the human
nose. However, little is known about the signaling cascade leading
to activation of WalKR in S. aureus.
The physiological milieu of the human nose has an important
influence on the adaptation of S. aureus to this ecological niche, and
the host signals which are sensed by the pathogen are largely
unknown. The expression of isdA is indicative of iron-limited
conditions in vivo, since this molecule was shown to be highly iron-
regulated [31]. The pathogen seems to be actively dividing in the
nose environment, as suggested by the expression of many of the
enzymes involved in cell-wall biosynthesis (tagO, tarK, atlA, sceD).
This notion is additionally supported by the fact that most of the
genes expressed in the human nose are those which are normally
expressed in vitro during the exponential growth phase (clfB, fnbA,
isdA, sceD, chp), indicating active S. aureus cells. On the other hand,
we found little indication that the typical stress response factors (recA,
relA, codY, sigB) are needed in the colonization process. They may be
required in a more hostile environment, e.g. during infection.
In summary, we could elucidate here for the first time the
expression pattern of S. aureus during asymptomatic colonization of
the human nose. So far, direct transcript analysis has been performed
during different kinds of infection [11,18,41,42,43,44,45]. Taken
together the results indicate that S. aureus is able to specifically adapt
to different niches in the human host. These findings signifi-
cantly enhance our understanding of the complex host-pathogen
interplay.
Methods
Ethics statement
The ethic committee of the University Hospital of Tu ¨bingen
approved the study design. Written consent was obtained from all
participants involved in the study according to their guidelines.
Study population, bacteriological analysis, and
characterization of bacterial isolates
Four healthy volunteers (two males and two females, median
age 32 [range 26–43]) with repeatedly S. aureus-positive, high
bacterial count nose swabs were selected for this study. Nose swabs
were immediately used for RNA isolation without any subcultur-
ing of the bacteria. 10 ml of each swab were used for
bacteriological analysis. Samples were quantitatively analyzed on
sheep blood agar plates and S. aureus was identified by Staphaurex
plus (Remel). All isolates were typed with pulsed-field gel
electrophoresis [46] and spa typing as described [47]. Detection
of PVL, mec, sak and the integrase type of prophages was done as
described [28,47], primers for chp and scn see Table S1.
RNA isolation
For in vitro transcript analysis, nose isolates were grown
overnight in CYPG (10 g/l casamino acid, 10g/l yeast extract,
5 g/l NaCl, 0.5% glucose and 0.06 M phosphoglycerate) [48],
diluted to an initial OD600 of 0.05 in fresh medium and grown to
the exponential (OD600=0.5) or post-exponential (OD600=
0.5+4h) phase. Bacteria were harvested by centrifugation and
dissolved in 1 ml Trizol reagent (Invitrogen). For in vivo transcript
analysis, a cotton wool swab was moistened in 250 ml nuclease-free
water and the left and right anterior nares of the human volunteers
were swabbed. The swab was vigorously vortexed and 10 ml of the
suspension were put aside for bacteriological analysis. The cotton
wool was removed from the swab using sterile tweezers and both
the suspension and the cotton wool were directly treated with 1 ml
of Trizol LS reagent (Invitrogen).
Bacteria were lysed and RNA isolation was performed as
described [41] with modifications to increase the amount of
isolated RNA. First, precipitation was performed for 60 min at
220uC with the addition of 0.5 M ammonium acetate and 50 mg/
ml GlycoBlue (Ambion). Second, after precipitation a prolonged
centrifugation step of 1 h at 12,000 g was carried out. The dried
RNA pellet was dissolved in 20 ml nuclease-free water.
To eliminate contaminating DNA each RNA sample was
digested with 8 U of RNase-free DNaseI (Roche), 5 mM MgCl2,
and 16 U of RNasin (Promega) for 30 min at 25uC. DNaseI
treatment was stopped using DNase inactivation reagent (Ambion).
Northern analysis
Northern blot analysis was performed as described [18]. As
controls S. aureus strains Newman [49], HG001 formerly named
RN1HG [24] and USA300 [50] were used.
S. aureus during Colonization
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Sequence-specific RNA standards for quantification were
prepared as described previously [41]. Briefly, gene-specific primers
with a 59-extension including the T7 promoter sequence (table S1)
were used in a standard PCR. T7-driven in vitro transcription was
performed in a standard transcription assay (T7-MEGAshortscript,
Ambion). After subsequent DNase I treatment, RNA was recovered
using the MEGAclear Kit (Ambion). RNA quantification was
performed spectrophotometrically. RNA standards were diluted to
1610
6, 3.16610
5,1 610
5, 3.16610
4,1 610
4 and 3.16610
3 copies/
ml. 1 ml of RNA standards, 1 ml (of a 1:100 dilution) of in vitro and
3 mlo fin vivo RNA were transcribed into cDNA using Super-
ScriptIII Reverse Transcriptase (Invitrogen) and 200 ng of random
hexamer primers (Fermentas). cDNAs were frozen at 220uCu s i n g
Eppendorf LoBind tubes (Eppendorf) for prolonged storage.
Quantitative real-time PCR was carried out using the Light-
Cycler instrument and the LightCycler DNA amplification kit for
hybridization probes or for SYBR Green (Roche) with cDNA
diluted 1:5 (in vivo) or 1:10 (in vitro). Reaction mixtures were
prepared using primers listed in table S1 or published primers
[18,41]. All primers were designed to account for possible gene
polymorphisms (if necessary, wobbles were introduced, as in the
case of eap and blhB) and were evaluated for optimal binding on
the genome-sequenced S. aureus strains in silico. In the case of
extensive polymorphisms of targets (e.g. eap) PCR efficiencies were
additionally determined experimentally. Possible cross-reactions
with S. epidermidis, a bacterial species often found alongside S. aureus
in nose specimens, were excluded. The number of copies of each
sample transcript was then determined with the aid of the
LightCycler software. The specificity of the PCR reaction was
verified on 3% agarose gels.
The absence of contaminating DNA was proven for each
sample by quantitative real-time PCR using gyrB-specific primers.
No amplification product could be detected in any of the samples.
Statistical analysis
Statistical analysis was performed with the Prism 4.0 package
(GraphPad Software) using the one-way ANOVA test and
Bonferroni’s multiple comparison post-test. P,0.05 was consid-
ered to be statistically significant.
Supporting Information
Table S1 Oligonucleotide primers and LightCycler hybridiza-
tion probes.
Found at: doi:10.1371/journal.pone.0010040.s001 (0.16 MB
DOC)
Table S2 S. aureus genes analyzed by quantitative real-time
PCR.
Found at: doi:10.1371/journal.pone.0010040.s002 (0.23 MB
DOC)
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